Bacteria-specific neutrophil dysfunction associated with interferon-stimulated gene expression in the acute respiratory distress syndrome

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Malcolm, Kenneth C ^a,b   Kret, Jennifer E ^a   Young, Robert L ^a,b   Poch, Katie R ^a   Caceres, Silvia M ^a   Douglas, Ivor S ^b,c   Coldren, Chris D ^b   Burnham, Ellen L ^b   Moss, Marc ^b   Nick, Jerry A ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERFERON; INTERFERON STIMULATED GENE FACTOR 15; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; SUPEROXIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IFIT1; TRANSCRIPTION FACTOR MX1; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CELL DEATH; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DIALYSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; IMMUNOMODULATION; MAJOR CLINICAL STUDY; NEUTROPHIL; PHAGOCYTOSIS; PHENOTYPE; PNEUMONIA; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS AUREUS; VIRUS INFECTION; CELL MOTION; CELL SEPARATION; COHORT ANALYSIS; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION; SPECIES DIFFERENCE; VIROLOGY; VIRUS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; CELL DEATH; CELL MOVEMENT; CELL SEPARATION; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; INTERLEUKIN-8; MALE; MICROBIAL VIABILITY; MIDDLE AGED; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RESPIRATORY DISTRESS SYNDROME, ADULT; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; SUPEROXIDES; VIRUSES; YOUNG ADULT;

EID: 79960017179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021958     Document Type: Article

References (61)

1. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, et al. (2005) Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33: 1191-1198.
2. Ely EW, Wheeler AP, Thompson BT, Ancukiewicz M, Steinberg KP, et al. (2002) Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med 136: 25-36.
3. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, et al. (2000) Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 28: 2187-2192.
4. Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, et al. (2007) Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med 35: 48-56.
5. Tsangaris I, Tsantes A, Bonovas S, Lignos M, Kopterides P, et al. (2009) The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res 123: 832-836.
6. Abraham E, (2003) Neutrophils and acute lung injury. Crit Care Med 31: S195-199.
7. Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ, (1999) Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 27: 1738-1744.
8. Borregaard N, Cowland JB, (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521.
9. Lee KS, Choi YH, Kim YS, Baik SH, Oh YJ, et al. (2008) Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir Med 102: 464-469.
10. Aggarwal A, Baker CS, Evans TW, Haslam PL, (2000) G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 15: 895-901.
11. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, et al. (1996) Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154: 602-611.
12. Lesur O, Kokis A, Hermans C, Fulop T, Bernard A, et al. (2000) Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit Care Med 28: 3814-3822.
13. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, et al. (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68: 1942-1945.
14. Mascellino MT, Delogu G, Pelaia MR, Ponzo R, Parrinello R, et al. (2001) Reduced bactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa of blood neutrophils from patients with early adult respiratory distress syndrome. J Med Microbiol 50: 49-54.
15. Martin TR, Pistorese BP, Hudson LD, Maunder RJ, (1991) The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am Rev Respir Dis 144: 254-262.
16. Rivkind AI SJ, Littleton M, De Gaetano A, Mamantov T, Laghi F, Stoklosa JC, (1991) Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock 33: 48-62.
17. Fialkow L, Fochesatto Filho L, Bozzetti MC, Milani AR, Rodrigues Filho EM, et al. (2006) Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care 10: R155.
18. Buckley JM, Wang JH, Redmond HP, (2006) Cellular reprogramming by gram-positive bacterial components: a review. J Leukoc Biol 80: 731-741.
19. Fan H, Cook JA, (2004) Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10: 71-84.
20. Stetson DB, Medzhitov R, (2006) Type I interferons in host defense. Immunity 25: 373-381.
21. Pichlmair A, Reis e Sousa C, (2007) Innate recognition of viruses. Immunity 27: 370-383.
22. Roers A, Hochkeppel HK, Horisberger MA, Hovanessian A, Haller O, (1994) MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis 169: 807-813.
23. Halminen M, Ilonen J, Julkunen I, Ruuskanen O, Simell O, et al. (1997) Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res 41: 647-650.
24. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109: 2066-2077.
25. Zaas AK, Chen M, Varkey J, Veldman T, Hero AO 3rd, et al. (2009) Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6: 207-217.
26. Rothberg MB, Haessler SD, Brown RB, (2008) Complications of viral influenza. Am J Med 121: 258-264.
27. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM, (1985) Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119: 101-110.
28. Malcolm KC, Worthen GS, (2003) Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem 278: 15693-15701.
29. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
30. Shiloh MU, Ruan J, Nathan C, (1997) Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect Immun 65: 3193-3198.
31. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr, (1984) Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 160: 1656-1671.
32. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, et al. (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104: 3878-3885.
33. Landolt-Marticorena C, Bonventi G, Lubovich A, Ferguson C, Unnithan T, et al. (2009) Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann Rheum Dis 68: 1440-1446.
34. Fessler MB, Malcolm KC, Duncan MW, Worthen GS, (2002) A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem 277: 31291-31302.
35. Wright HJ, Matthews JB, Chapple IL, Ling-Mountford N, Cooper PR, (2008) Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. J Immunol 181: 5775-5784.
36. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, et al. (1999) Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103: 851-858.
37. Nick JA, Young SK, Arndt PG, Lieber JG, Suratt BT, et al. (2002) Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J Immunol 169: 5260-5269.
38. Erwig LP, Henson PM, (2007) Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 171: 2-8.
39. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, et al. (2005) Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175: 3907-3919.
40. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, et al. (2010) Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2: 560-575.
41. Bogdan C, Mattner J, Schleicher U, (2004) The role of type I interferons in non-viral infections. Immunol Rev 202: 33-48.
42. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, et al. (2007) Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 178: 3126-3133.
43. Carrero JA, Calderon B, Unanue ER, (2004) Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med 200: 535-540.
44. O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, et al. (2004) Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 200: 437-445.
45. Kelly-Scumpia KM, Scumpia PO, Delano MJ, Weinstein JS, Cuenca AG, et al. (2010) Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med 207: 319-326.
46. Malcolm KC, Arndt PG, Manos EJ, Jones DA, Worthen GS, (2003) Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol 284: L663-670.
47. Hampton MB, Kettle AJ, Winterbourn CC, (1996) Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. Infect Immun 64: 3512-3517.
48. Stockinger S, Materna T, Stoiber D, Bayr L, Steinborn R, et al. (2002) Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol 169: 6522-6529.
49. Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, et al. (2004) Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 279: 44123-44132.
50. Sellers TF Jr, Schulman J, Bouvier C, Mc CR, Kilbourne ED, (1961) The influence of influenza virus infection on exogenous staphylococcal and endogenous murine bacterial infection of the bronchopulmonary tissues of mice. J Exp Med 114: 237-256.
51. McCullers JA, (2006) Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19: 571-582.
52. Sakamoto E, Hato F, Kato T, Sakamoto C, Akahori M, et al. (2005) Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2. J Leukoc Biol 78: 301-309.
53. Gungor N, Pennings JL, Knaapen AM, Chiu RK, Peluso M, et al. (2010) Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils. Respir Res 11: 24.
54. Gyllenhammar H, Hafstrom I, Ringertz B, Uden AM, Palmblad J, (1988) Recombinant human leukocyte interferon modulates neutrophil function in vitro. J Interferon Res 8: 441-449.
55. Wang K, Scheel-Toellner D, Wong SH, Craddock R, Caamano J, et al. (2003) Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J Immunol 171: 1035-1041.
56. Little R, White MR, Hartshorn KL, (1994) Interferon-alpha enhances neutrophil respiratory burst responses to stimulation with influenza A virus and FMLP. J Infect Dis 170: 802-810.
57. Loeb KR, Haas AL, (1992) The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267: 7806-7813.
58. Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, et al. (2003) Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun 309: 533-539.
59. Accola MA, Huang B, Al Masri A, McNiven MA, (2002) The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum. J Biol Chem 277: 21829-21835.
60. Guo J, Hui DJ, Merrick WC, Sen GC, (2000) A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 19: 6891-6899.
61. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, et al. (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300: 413-422.